Camurus AB (publ) (STO:CAMX)
505.00
-6.50 (-1.27%)
May 28, 2025, 12:59 PM CET
Camurus AB Revenue
Camurus AB had revenue of 558.34M SEK in the quarter ending March 31, 2025, with 43.17% growth. This brings the company's revenue in the last twelve months to 2.04B, up 11.69% year-over-year. In the year 2024, Camurus AB had annual revenue of 1.87B with 8.78% growth.
Revenue (ttm)
2.04B
Revenue Growth
+11.69%
P/S Ratio
14.73
Revenue / Employee
7.68M
Employees
256
Market Cap
29.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.87B | 150.73M | 8.78% |
Dec 31, 2023 | 1.72B | 760.51M | 79.52% |
Dec 31, 2022 | 956.34M | 355.77M | 59.24% |
Dec 31, 2021 | 600.57M | 264.57M | 78.74% |
Dec 31, 2020 | 336.00M | 230.39M | 218.16% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.30B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Medicover AB | 23.56B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |
Vitrolife AB | 3.61B |
Camurus AB News
- 4 weeks ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 7 months ago - Camurus AB (CAMRF) Q3 2024 Earnings Call Highlights: Record Profit and Revenue Growth Amid ... - GuruFocus
- 7 months ago - Q3 2024 Camurus AB Earnings Call Transcript - GuruFocus
- 7 months ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 1 year ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire